Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
13.
Eur J Hosp Pharm ; 28(1): 10-15, 2021 01.
Artículo en Inglés | MEDLINE | ID: covidwho-961084

RESUMEN

INTRODUCTION: Hospital admissions from COVID-19 initially increased rapidly within the UK. National Health Service (NHS) field hospitals are part of a capacity building response built at great scale and speed to respond to the anticipated increased demand the NHS faces during this time. NHS Nightingale Hospital Birmingham (NHB) is modelled to treat mild to moderate (non-critical care) COVID-19 disease, to provide step-down capacity for patients in recovery, or for palliating patients in the dying phase of their disease in the Midlands. Opportunities and challenges presented for optimal medicines management (MM) during the development of the NHB are investigated, and a framework developed to support future NHS field hospitals of this model. METHODS: A team, comprised of an associate medical director, trust chief pharmacist and senior pharmacists iteratively developed a framework to convert the large non-hospital setting into a functioning NHS field hospital with standardised MM processes adjusted appropriately to cope with operational constraints in the pandemic situation. NHB has, because of its repurposing, both challenges and advantages affecting MM that influence development of the framework. Throughout implementation, a 7-week period between announcement and opening, there was continuous evaluation, external stakeholder validation and peer review. RESULTS: The PESTLE model, a mechanism of analysis to identify elements of a project environment (Political, Environmental, Social, Technological, Legal and Economic), was applied to identify influencing factors and support detailed project planning. Compliance with medicines legislation was at the forefront of all MM process development for the NHB field hospital. Internal factors were identified by the core MM team, resulting in a workforce, education & training and clinical pharmacy MM plan. DISCUSSION: MM processes are extensive and integral to NHS field hospitals. The presented framework of influencing factors may support future NHS field hospital development. It is pertinent to have a broad team working approach to any large-scale project such as outlined here, and suggest the identified factors be used as a core framework for development of any future MM processes in NHS field hospitals.


Asunto(s)
COVID-19 , Administración Hospitalaria/tendencias , Administración del Tratamiento Farmacológico/organización & administración , Unidades Móviles de Salud/organización & administración , Pandemias , Medicina Estatal/organización & administración , Planificación de Instituciones de Salud , Capacidad de Camas en Hospitales/estadística & datos numéricos , Humanos , Sistemas de Medicación en Hospital , Administración del Tratamiento Farmacológico/legislación & jurisprudencia , Modelos Organizacionales , Política Organizacional , Farmacéuticos , Servicio de Farmacia en Hospital , Medicina Estatal/legislación & jurisprudencia , Reino Unido , Recursos Humanos
16.
Br J Nurs ; 29(17): 1042-1043, 2020 Sep 24.
Artículo en Inglés | MEDLINE | ID: covidwho-797628

RESUMEN

Richard Griffith, Senior Lecturer in Health Law at Swansea University, discusses the lawfulness of instructions to issue bulk do not attempt resuscitation orders during the COVID19 pandemic.


Asunto(s)
Infecciones por Coronavirus/epidemiología , Pandemias , Neumonía Viral/epidemiología , Órdenes de Resucitación/legislación & jurisprudencia , COVID-19 , Humanos , Legislación de Enfermería , Medicina Estatal/legislación & jurisprudencia , Reino Unido/epidemiología
17.
Br J Nurs ; 29(15): 906-907, 2020 Aug 13.
Artículo en Inglés | MEDLINE | ID: covidwho-714350

RESUMEN

John Tingle, Lecturer in Law, Birmingham Law School, University of Birmingham discusses the recently published Cumberlege report on medicines and medical devices safety.


Asunto(s)
Informes Anuales como Asunto , Seguridad del Paciente , Medicina Estatal/legislación & jurisprudencia , COVID-19 , Infecciones por Coronavirus/epidemiología , Humanos , Pandemias , Neumonía Viral/epidemiología , Reino Unido/epidemiología
18.
J Med Ethics ; 46(10): 662-667, 2020 10.
Artículo en Inglés | MEDLINE | ID: covidwho-705135

RESUMEN

In March 2020, the Government produced a document entitled "Responding to COVID-19: The Ethical Framework for Adult Social Care" ('The Ethical Framework'). In this article, we summarise the key features of the proposed ethical framework and subject it to critical analysis. We highlight three primary issues. First, the emphasis placed on autonomy as the primary ethical principle. We argue if ever there was a context in which autonomy should dominate the ethical analysis, this is not it. Second, we examine the interface between ethics and law which is largely overlooked in the document. Finally, we explore the surprising lack of attention paid to the concept of responsibility and communal obligations within the framework.


Asunto(s)
Infecciones por Coronavirus/terapia , Toma de Decisiones/ética , Análisis Ético , Ética Médica , Legislación Médica/ética , Autonomía Personal , Neumonía Viral/terapia , Responsabilidad Social , Adulto , Betacoronavirus , COVID-19 , Infecciones por Coronavirus/epidemiología , Teoría Ética , Humanos , Pandemias , Neumonía Viral/epidemiología , SARS-CoV-2 , Medicina Estatal/ética , Medicina Estatal/legislación & jurisprudencia , Reino Unido
20.
Br J Nurs ; 29(12): 716-717, 2020 Jun 25.
Artículo en Inglés | MEDLINE | ID: covidwho-613346

RESUMEN

John Tingle, Lecturer in Law, Birmingham Law School, University of Birmingham, discusses how the Courts may view clinical negligence claims brought by families who have lost loved ones during the pandemic.


Asunto(s)
Infecciones por Coronavirus/terapia , Mala Praxis/legislación & jurisprudencia , Pandemias , Seguridad del Paciente/legislación & jurisprudencia , Neumonía Viral/terapia , Medicina Estatal/legislación & jurisprudencia , COVID-19 , Infecciones por Coronavirus/epidemiología , Humanos , Neumonía Viral/epidemiología , Reino Unido/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA